Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
1140
-
Total 13F shares, excl. options
-
177,270,767
-
Shares change
-
-944,711
-
Total reported value, excl. options
-
$62,594,382,952
-
Value change
-
-$269,008,690
-
Put/Call ratio
-
1.59%
-
Number of buys
-
474
-
Number of sells
-
-541
-
Price
-
$353.31
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2018
1,280 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2018.
BIOGEN INC. - COM (BIIB) has 1,140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177,270,767 shares
.
Largest 10 shareholders include BlackRock Inc. (16,498,360 shares), PRIMECAP MANAGEMENT CO/CA/ (14,873,796 shares), Vanguard Group Inc (14,814,125 shares), Clearbridge Investments, LLC (8,845,449 shares), STATE STREET CORP (8,844,835 shares), WELLINGTON MANAGEMENT GROUP LLP (5,534,010 shares), FMR LLC (4,322,186 shares), Invesco Ltd. (3,609,267 shares), ALLIANCEBERNSTEIN L.P. (3,121,144 shares), and AQR CAPITAL MANAGEMENT LLC (3,024,037 shares).
This table shows the top 1140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.